Pliant Therapeutics, Inc.
PLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746473
No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Pliant Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 114 | 1 | 100 | −13 |
| Shares | 51.5M | 199.9K | 50.4M | −884.8K (−1.7%) |
| Value | $59.7M | $231.9K | $74.7M | +$15.2M (+25.5%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Pliant Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 4,338,394 | $6.42M | 0.01% |
| Eversept Partners, LP | 824,594 | $1.22M | 0.09% |
| Jacobs Levy Equity Management, Inc | 367,113 | $543.3K | 0.00% |
| Marshall Wace, LLP | 299,461 | $443.2K | 0.00% |
| Stonepine Capital Management, LLC | 289,237 | $428.1K | 0.35% |
| Voleon Capital Management LP | 149,041 | $220.6K | 0.01% |
| Torno Capital, LLC | 130,916 | $193.8K | 0.03% |
| Bluefin Capital Management, LLC | – | $61.0K | 0.03% |
| FNY Investment Advisers, LLC | 25,400 | $37.0K | 0.01% |
| Connor, Clark & Lunn Investment Management Ltd. | 24,340 | $36.0K | 0.00% |
| Fortitude Family Office, LLC | 1,278 | $1.89K | 0.00% |
| Rockefeller Capital Management L.P. | 1,085 | $1.61K | 0.00% |
| Bell Investment Advisors, Inc | 307 | $455 | 0.00% |
Sold out (26)
Institutions that held Pliant Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
Not filed for Q3 2025 yet (1)
Institutions that held Pliant Therapeutics, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Congress Wealth Management LLC | 199,920 | $231.9K |